Blog
Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration with Axovia Therapeutics Ltd
Eagle Materials Announces Start Up of New Texas Lehigh Cement Company Slag Facility in Texas
Eagle Materials Inc. (NYSE: EXP) announced plans today for Texas Lehigh Cement Company, a 50/50 joint venture between Eagle and Heidelberg Materials North America, to start-up a new slag cement
Sunoco LP and NuStar Energy L.P. Announce Expiration of Hart-Scott-Rodino Act Waiting Period
Sunoco LP (NYSE: SUN) (“Sunoco” or “SUN”) and NuStar Energy L.P. (NYSE: NS) (“NuStar” or “NS”) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust
AdvanSix to Release First Quarter Financial Results and Hold Investor Conference Call on May 3
AdvanSix (NYSE: ASIX) will issue its first quarter 2024 financial results before the opening of the New York Stock Exchange on Friday, May 3. The company will also hold a conference call with
Ferguson plc (“Company”): Director/PDMR Shareholding
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (“PDMRs”) IN ORDINARY SHARES OF 10p EACH IN THE COMPANY (“Shares”)
The attached notifications, which have been
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
Pfizer Inc. (NYSE: PFE) today announced positive top-line immunogenicity and safety data from the ongoing pivotal Phase 3 clinical trial (NCT05842967) MONeT (RSV IMmunizatiON Study for AdulTs at
Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will attend the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place at the Metro Toronto
Corebridge Financial Completes Sale of UK Life Insurance Business to Aviva plc
Corebridge Financial, Inc. (NYSE: CRBG) today announced that it has completed the previously announced sale of its UK life insurance business (operating as AIG Life Limited) to Aviva plc.
The
Cushman & Wakefield Appoints Luke Herbert as Global Treasurer
Cushman & Wakefield (NYSE: CWK), a leading global real estate services firm, today announced Luke Herbert has joined the firm as Senior Vice President, Global Treasurer. Herbert will be based in
Power Integrations to Release First-Quarter Financial Results on May 7
Power Integrations (Nasdaq: POWI) will release its first-quarter financial results after market hours on Tuesday, May 7, 2024, and will host a conference call that day beginning at 1:30 p.m
Hilton Grand Vacations Successfully Reprices Term Loan B
Hilton Grand Vacations Inc. (NYSE:HGV) announces today the successful re-pricing of its existing $1.3 billion Term Loan B, maturing Aug. 2, 2028. The new pricing will be SOFR plus 250 basis points
Perion Network Announces Filing of Annual Report on Form 20-F for Fiscal Year 2023
Perion Network Ltd. (NASDAQ & TASE: PERI), a technology leader in connecting advertisers to consumers across all major digital channels, announced today the filing of its annual report on Form 20-F
Unitaid Awards Medincell up to $6 million Extension Grant to Fight Malaria
Global health agency Unitaid has awarded Medincell (Paris:MEDCL) an extension grant of up to US$ 6 million over three years to fund the clinical phase 1 activities of long-acting injectable
MaaT Pharma Presents Promising Preclinical Data at AACR for MaaT034 Aiming To Improve Patients’ Responses to Immunotherapies
Regulatory News:
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to
As Salesforce Growth Eases, U.S. Firms Map Out Projects
U.S. enterprises continue to work with service providers on implementing and operating Salesforce applications amid moderating growth in demand for the company’s applications, according to a new
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
AbCellera (Nasdaq: ABCL) today announced new data on its T-cell engager (TCE) programs at the American Association for Cancer ResearchⓇ (AACR) Annual Meeting 2024 at the San Diego Convention
Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through
Humana Focuses on Reducing Health Disparities and Making Healthy Living Possible for All
Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, announced the release of its 2023 Impact Report, which includes details on the company’s continued commitment
Cloudflare and Booz Allen Hamilton Now Delivering Rapid Incident Response for Enterprises Under Attack
Cloudflare, Inc. (NYSE: NET), the leading connectivity cloud company, today announced a collaboration with Booz Allen Hamilton (NYSE: BAH), to support enterprises under attack by providing
State Street’s Research Team Announces Academic Partnership with Daniel Drezner of The Fletcher School, expanding Markets Research Capabilities in Arena of Geopolitical Risk
State Street Corporation (NYSE: STT) today announced a new partnership with Daniel W. Drezner, Professor of International Politics at The Fletcher School, the graduate school of global affairs at
Armstrong World Industries Schedules First Quarter 2024 Earnings Release and Conference Call
Armstrong World Industries, Inc. (NYSE:AWI), a leader in the design, innovation and manufacture of ceiling and wall solutions in the Americas, will release its first-quarter 2024 results before the
UiPath Named a Leader for Second Consecutive Year in the Everest Group Intelligent Document Processing (IDP) Products PEAK Matrix® Assessment 2024
UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced that it has been named a Leader in Intelligent Document Processing for the second consecutive year in
Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the acceptance of two abstracts for poster presentation at
Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral


